GLP-1 agonists were originally approved by the U.S
How Januvia and Rybelsus Work in Type 2 Diabetes Januvia (sitagliptin) belongs to a class of medications called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors)
GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
Can I combine T-Shape 2 with other treatments
Understanding these nuances is vital for healthcare professionals and laboratory technicians striving to optimize their practices